Application of BAROS’ questionnaire in obese patients undergoing bariatric surgery with 2 years of evolution

Abstract

-Background -In recent decades, the high prevalence of obesity in the general population has brought serious concerns in terms of public health. Contrarily to conventional treatment involving dieting and physical exercising, often ineffective in generating long term results, bariatric operations have been an effective method for sustained weight loss in morbidly obese individuals. The Bariatric Analysis and Reporting Outcome System (BAROS) is an objective and recognized system in the overall evaluation of results after bariatric surgery. Objective -To investigate results concerning a casuistic of morbidly obese patients undergoing bariatric surgery over a 2-year follow-up in terms of weight loss, related medical conditions, safety and changes in quality of life. Methods -A total of 120 obese (17 male and 103 female) patients, who underwent bariatric surgery, were assessed and investigated using the BAROS system after a 2-year follow-up. Results -Patients obtained a mean excess weight loss of 74.6 (±15.9) % and mean body mass index reduction of 15.6 (±4.4) Kg/m 2 . Pre-surgical comorbidities were present in 71 (59%) subjects and they were totally (86%) or partially (14%) resolved. Complications resulting specifically from the surgical procedure were observed in 4.2% of cases (two bowel obstructions requiring re-operation, and three stomal stenosis treated with endoscopic dilation). Sixteen subjects (13% of total number of patients) presented minor clinical complications managed through outpatient care. The final scores for the BAROS questionnaire showcased excellent to good results in 99% of cases (excellent 44%, very good 38%, good 23%, acceptable 1%). Conclusion -According to the BAROS questionnaire, bariatric surgery is a safe and effective method for managing obesity and associated clinical comorbidities, allowing for satisfactory results after a 2-year follow-up. Future studies should address other clinical and psychosocial variables that impact outcome as well as allow for longer follow-ups. HEADINGS -Morbid obesity. Bariatric surgery. Body weight. Quality of life.Declared conflict of interest of all authors: none Disclosure of funding: no funding received

Weight loss and quality of life after bariatric surgery: a 2-year longitudinal study

“…Beyond weight loss, the benefit of bariatric surgery is also improved QoL for patients [9], as shown by the present study 2 years after surgery. Furthermore, while men had a higher average preoperative level of global QoL than women, it should be noted that, 2 years after surgery, results showed no difference between them, as confirmed by data in the literature [5].…”

“…Partial weight regain has already been referred to in the literature [5,7] and can be explained, in particular, by the continuation of previous life habits (poor eating habits, sedentary lifestyle, etc.) in the months after surgery.…”

“…With only a small number of contraindications, bariatric surgery seems to be recognized today as an effective therapeutic alternative for people with morbid obesity [5,6]. Today, 2 main types of surgical procedures are performed and a number of studies have investigated the effects of these 2 techniques on the evolution of BMI [7].…”

“…It is especially recognized today that quality of life (QoL) is a relevant variable to consider in the weight loss process and psychologic monitoring of patients [10]. Studies conducted to date have shown health-related QoL, assessed via the bariatric analysis and reporting outcome system (BAROS) [5] or via the short form-36 Questionnaire and Moorehead-Ardelt Quality of Life Questionnaire II [11], is enhanced after bariatric surgery using the Rouxen-Y GB technique or laparoscopic gastric banding and reaches a similar level to that of the general population after 2 or 3 years. In a further study measuring QoL in the year after laparoscopic SG, Bobowicz and colleagues [12] likewise demonstrated a significant increase in the global BAROS score.…”

Obesidade

“…Mesmo assim efeitos adversos citados na derivação bilopancreática à Scopinaro acontecem porém de maneira mais branda. A perda de peso oscila em torno de 75% a 80%, comparável à da Derivação gástrica em Y de Roux 15,16 .…”